Wang Jun Wen - Net Worth and Insider Trading
Wang Jun Wen Net Worth
The estimated net worth of Wang Jun Wen is at least $0 dollars as of 2024-12-14. Wang Jun Wen is the Independent director of Hunan Er-Kang Pharmaceutical Co Ltd and owns about 0 shares of Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) stock worth over $0. Details can be seen in Wang Jun Wen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wang Jun Wen has not made any transactions after 2020-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Wang Jun Wen
Wang Jun Wen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wang Jun Wen owns 1 companies in total, including Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) .
Click here to see the complete history of Wang Jun Wen’s form 4 insider trades.
Insider Ownership Summary of Wang Jun Wen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SZSE:300267 | Hunan Er-Kang Pharmaceutical Co Ltd | 2020-02-05 | Independent director |
Wang Jun Wen Latest Holdings Summary
Wang Jun Wen currently owns a total of 1 stock. Wang Jun Wen owns 0 shares of Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) as of February 5, 2020, with a value of $0.
Latest Holdings of Wang Jun Wen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SZSE:300267 | Hunan Er-Kang Pharmaceutical Co Ltd | 2020-02-05 | 0 | 3.44 | 0 |
Holding Weightings of Wang Jun Wen
Wang Jun Wen Form 4 Trading Tracker
According to the SEC Form 4 filings, Wang Jun Wen has made a total of 1 transactions in Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Hunan Er-Kang Pharmaceutical Co Ltd is the acquisition of 1,900 shares on February 5, 2020, which cost Wang Jun Wen around $9,899.
Insider Trading History of Wang Jun Wen
- 1
Wang Jun Wen Trading Performance
GuruFocus tracks the stock performance after each of Wang Jun Wen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wang Jun Wen is -25.14%. GuruFocus also compares Wang Jun Wen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wang Jun Wen within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wang Jun Wen's insider trading performs compared to the benchmark.
Performance of Wang Jun Wen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.81 | | | | | |
| Relative Return to S&P 500(%) | 0.51 | | | | | |
Wang Jun Wen Ownership Network
Ownership Network List of Wang Jun Wen
Ownership Network Relation of Wang Jun Wen
Wang Jun Wen Owned Company Details
What does Hunan Er-Kang Pharmaceutical Co Ltd do?
Who are the key executives at Hunan Er-Kang Pharmaceutical Co Ltd?
Wang Jun Wen is the Independent director of Hunan Er-Kang Pharmaceutical Co Ltd. Other key executives at Hunan Er-Kang Pharmaceutical Co Ltd include Independent director Zuo Tian Fang , Supervisors Qi Yang , and Supervisors Li Yi Guo .
Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hunan Er-Kang Pharmaceutical Co Ltd Insider Transactions
Wang Jun Wen Mailing Address
Above is the net worth, insider trading, and ownership report for Wang Jun Wen. Currently GuruFocus does not have mailing address information for Wang Jun Wen.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
